Nanological stands at the forefront of MedTech innovation, addressing the pressing challenge of sepsis, which affects 50 million annually. Using optomechanical detection, we provide a label-free, multiparametric analysis of bacteria in blood within minutes. Integrated with a cloud-based AI platform, Nanological's technology not only facilitates rapid pathogen detection but also differentiates between bacterial types. This prompt diagnosis, unparalleled in speed, challenges traditional methods that involve waits of hours or even days — a critical factor considering septic shock mortality rises by 10% every hour. Our rapid pathogen identification will equip healthcare professionals to refine treatment strategies, significantly enhancing survival rates.
.png)
